A Chinese pharmaceutical giant is to be handed £151m to substantially grow its operations in Liverpool and create 174 jobs.
Pharmaron has been named as one of the beneficiaries of the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants backed by the government and private investment.
The company will now increase its production capacity for critical gene therapy and vaccine components four-fold as well a secure as further 156 roles.
